Drugs / Allerslit forte
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT00623701 | Mar 2008 → Oct 2011 | allergic disease, conjunctivitis, rhinitis | Allergopharma GmbH & Co. KG | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Allerslit forte | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00623701 ↗ |